RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:a-lgal-HEX-1:5|6:d
4b:b-dgal-HEX-1:5
5b:a-lgal-HEX-1:5|6:d
LIN
1:1d(2+1)2n
2:1o(3+1)3d
3:1o(4+1)4d
4:4o(2+1)5d

• Hiratsuka K et al. Identification of a D-glycero-D-manno-heptosyltransferase gene from Helicobacter pylori. J Bacteriol. 2005 Aug;187:(15):5156-65. doi: 10.1128/JB.187.15.5156-5165.2005. PMID: 16030209.

• Logan SM et al. Functional genomics of Helicobacter pylori: identification of a beta-1,4 galactosyltransferase and generation of mutants with altered lipopolysaccharide. Mol Microbiol. 2000 Mar;35:(5):1156-67. doi: 10.1046/j.1365-2958.2000.01784.x. PMID: 10712696.

• Monteiro MA et al. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between h. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. J Biol Chem. 1998 May 8;273:(19):11533-43. doi: 10.1074/jbc.273.19.11533. PMID: 9565568.

• Wang G et al. Molecular genetic basis for the variable expression of Lewis Y antigen in Helicobacter pylori: analysis of the alpha (1,2) fucosyltransferase gene. Mol Microbiol. 1999 Feb;31:(4):1265-74. doi: 10.1046/j.1365-2958.1999.01268.x. PMID: 10096092.

• Appelmelk BJ et al. Phase variation in H type I and Lewis a epitopes of Helicobacter pylori lipopolysaccharide. Infect Immun. 2000 Oct;68:(10):5928-32. doi: 10.1128/iai.68.10.5928-5932.2000. PMID: 10992504.

• Altman E et al. Characterization of murine monoclonal antibodies against Helicobacter pylori lipopolysaccharide specific for Lex and Ley blood group determinants. Biochem Cell Biol. 2005 Oct;83:(5):589-96. doi: 10.1139/o05-052. PMID: 16234847.

• Shetye JD et al. Tumor-associated antigens common to humans and chemically induced colonic tumors of the rat. Cancer Res. 1990 Oct 1;50:(19):6358-63. PMID: 2400995.

• Yazawa S et al. Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer. Jpn J Cancer Res. 1993 Jun;84:(6):641-8. doi: 10.1111/j.1349-7006.1993.tb02024.x. PMID: 8340252.

• Pour PM et al. Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res. 1988 Oct 1;48:(19):5422-6. PMID: 3166398.

• Lloyd KO et al. Mouse monoclonal antibody F-3 recognizes the difucosyl type-2 blood group structure. Immunogenetics. 1983;17:(5):537-41. doi: 10.1007/BF00696877. PMID: 6188690.

• Shetye JD et al. Normal colon of Sprague-Dawley rats. An immunohistochemical study. Anat Embryol (Berl). 1992;185:(1):69-76. doi: 10.1007/BF00213602. PMID: 1736686.

• Zhu ZM et al. Monoclonal antibody directed to Le(y) oligosaccharide inhibits implantation in the mouse. Biol Reprod. 1995 Apr;52:(4):903-12. doi: 10.1095/biolreprod52.4.903. PMID: 7780013.

• Nakamura J et al. The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma. Glycoconj J. 1997 Jan;14:(1):81-7. doi: 10.1023/a:1018517116368. PMID: 9076517.

• Shetye J et al. The tumor-associated antigens BR55-2, GA73-3 and GICA 19-9 in normal and corresponding neoplastic human tissues, especially gastrointestinal tissues. Anticancer Res. 1989 Mar-Apr;9:(2):395-404. PMID: 2665636.

• Yazawa S et al. Tumor-related expression of alpha1,2fucosylated antigens on colorectal carcinoma cells and its suppression by cell-mediated priming using sugar acceptors for alpha1,2fucosyltransferase. Glycobiology. 2002 Sep;12:(9):545-53. doi: 10.1093/glycob/cwf070. PMID: 12213787.

• Abe K et al. The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant). J Biol Chem. 1983 Oct 10;258:(19):11793-7. PMID: 6194156.

• Yin BW et al. Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer. Int J Cancer. 1996 Feb 8;65:(4):406-12. doi: 10.1002/(SICI)1097-0215(19960208)65:4<406::AID-IJC2>3.0.CO;2-0. PMID: 8621218.

• Blaszczyk-Thurin M et al. Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy. J Biol Chem. 1987 Jan 5;262:(1):372-9. PMID: 2432062.

• Thurin M et al. SA-Lea and tumor metastasis: the old prediction and recent findings. Hybrid Hybridomics. 2002 Apr;21:(2):111-6. doi: 10.1089/153685902317401708. PMID: 12031100.

• Sakamoto J et al. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res. 1986 Mar;46:(3):1553-61. PMID: 3510728.

• Hirashima K et al. High idiotypic connectivity of the VH7183-encoded antibodies directed to a murine embryonic carbohydrate antigen, Lewis Y, as ascertained by syngenic anti-idiotype monoclonal antibodies. J Immunol. 1990 Jul 1;145:(1):224-32. PMID: 1972718.

• Naitoh H et al. The recognition of cancer-associated fucosylated antigens in colorectal cancer by a novel monoclonal antibody, YB-2. Surg Today. 1994;24:(4):382-4. doi: 10.1007/BF02348574. PMID: 8038519.

• Cao Y et al. The fucosylated histo-blood group antigens H type 2 (blood group O, CD173) and Lewis Y (CD174) are expressed on CD34+ hematopoietic progenitors but absent on mature lymphocytes. Glycobiology. 2001 Aug;11:(8):677-83. doi: 10.1093/glycob/11.8.677. PMID: 11479278.

• Blaineau C et al. The glycosidic antigen recognised by a novel monoclonal antibody, 75.12, is developmentally regulated on mouse embryonal carcinoma cells. EMBO J. 1983;2:(12):2217-22. PMID: 6667675.

• Muroi K et al. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens:absence of reactivity with normal hematopoietic progenitor cells. Blood. 1992 Feb 1;79:(3):713-9. PMID: 1370643.

• Baldus SE et al. Expression of alpha-3/4-monofucosylated polylactosaminoglycan epitope, as defined by monoclonal antibody FW6, is a marker of the colorectal adenoma-carcinoma sequence. Cancer. 1995 Sep 15;76:(6):954-60. doi: 10.1002/1097-0142(19950915)76:6<954::aid-cncr2820760607>3.0.co;2-5. PMID: 8625220.

• Dohi T et al. Immunohistochemical study of carbohydrate antigen expression in gastric carcinoma. Gastroenterol Jpn. 1989 Jun;24:(3):239-45. doi: 10.1007/BF02774320. PMID: 2663606.

• Jovanovic R et al. Blood-group-related antigen Lewis(x) and Lewis(y) in the differential diagnosis of cholangiocarcinoma and hepatocellular carcinoma. Arch Pathol Lab Med. 1989 Feb;113:(2):139-42. PMID: 2537068.

• Childs RA et al. Blood group-active carbohydrate chains on the receptor for epidermal growth factor of A431 cells. EMBO J. 1984 Oct;3:(10):2227-33. PMID: 6094178.

• Dohi T et al. Immunohistological and biochemical detection of fucosylated polylactosamine antigen with monoclonal antibody ACFH18 in gastric cancer and normal gastric mucosa. Jpn J Cancer Res. 1990 Jun-Jul;81:(6-7):676-81. doi: 10.1111/j.1349-7006.1990.tb02626.x. PMID: 2119368.

• Kaneko T et al. Preparation of mouse-human chimeric antibody to an embryonic carbohydrate antigen, Lewis Y. J Biochem. 1993 Jan;113:(1):114-7. doi: 10.1093/oxfordjournals.jbchem.a123993. PMID: 8095932.

• Adachi M et al. Expression of Ley antigen in human immunodeficiency virus-infected human T cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC). J Exp Med. 1988 Feb 1;167:(2):323-31. doi: 10.1084/jem.167.2.323. PMID: 3258005.

• Brown A et al. A monoclonal antibody against human colonic adenoma recognizes difucosylated Type-2-blood-group chains. Biosci Rep. 1983 Feb;3:(2):163-70. doi: 10.1007/BF01121947. PMID: 6189529.

• Imai K et al. Circulating blood group-related antigen(s) in cancer patients detected by the monoclonal antibodies produced against hepatocellular carcinoma cell line. Tumour Biol. 1985;6:(3):257-72. PMID: 2416034.

• Friedman PN et al. BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells. Cancer Res. 1993 Jan 15;53:(2):334-9. PMID: 8417827.

• Croce MV et al. Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision. Pathol Oncol Res. 2007;13:(2):130-8. doi: 10.1007/BF02893488. PMID: 17607374.

• Kitamura K et al. Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants. Proc Natl Acad Sci U S A. 1994 Dec 20;91:(26):12957-61. doi: 10.1073/pnas.91.26.12957. PMID: 7809154.

• Suzuki M et al. Le(y) glycolipid acts as a co-factor for tumor procoagulant activity. Int J Cancer. 1997 Dec 10;73:(6):903-9. doi: 10.1002/(sici)1097-0215(19971210)73:6<903::aid-ijc24>3.0.co;2-3. PMID: 9399674.

• Holmes EH et al. Oncofetal expression of Lex carbohydrate antigens in human colonic adenocarcinomas. Regulation through type 2 core chain synthesis rather than fucosylation. J Biol Chem. 1987 Aug 15;262:(23):11331-8. PMID: 3112156.